Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Manente

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Tumori|March 18, 1999
Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinomaM Colleoni, G Vicario, P Manente, et al.
Chirurgia Italiana|February 1, 1981
[Early gastric cancer: a retrospective study of our cases (1974-1979)]S Bertazzo, G Pesce, V G Valmachino, et al.
Oncology Reports|May 21, 2011
Feasibility and tolerance of Cisplatin and Fluorouracil infusion in elderly patients with squamous-cell carcinomaM Colleoni, L Boni, P Nelli, et al.
Tumori|May 1, 1995
Pain at tumor site after vinorelbine injection: description of an unexpected side effectM Colleoni, F Gaion, G Vicario, et al.
American Journal of Clinical Oncology|August 1, 1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancerM Colleoni, C Graiff, G Vicario, et al.
Oncology Reports|May 20, 2011
Intermittent continuous infusion of fluorouracil, low-dose oral leucovorin and oral etoposide in advanced gastric cancerM Colleoni, G Vicario, C Graiff, et al.
American Journal of Clinical Oncology|June 1, 1997
Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinomaM Colleoni, C Graiff, P Nelli, et al.
Tumori|September 1, 1996
Response to chemotherapy of brain metastases from malignant pleural mesotheliomaM Colleoni, G Liessi, C Avventi, et al.
Tumori|April 30, 1980
[Cardiotoxicity induced by 5-fluorouracil. A case report]P Manente, R Buchberger, G Valmachino, et al.
La Clinica Terapeutica|July 15, 1981
[Cimetidine and primary hyperparathyroidism: failure of reduction of blood levels of parathyroid hormone in 5 cases of primary hyperparathyroidism]P Gasparoni, G Rota, D Fioretti, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Tumori|March 18, 1999
Activity and tolerability of courses of intra-arterial chemotherapy followed by chemoembolization in unresectable hepatocellular carcinomaM Colleoni, G Vicario, P Manente, et al.
Chirurgia Italiana|February 1, 1981
[Early gastric cancer: a retrospective study of our cases (1974-1979)]S Bertazzo, G Pesce, V G Valmachino, et al.
Oncology Reports|May 21, 2011
Feasibility and tolerance of Cisplatin and Fluorouracil infusion in elderly patients with squamous-cell carcinomaM Colleoni, L Boni, P Nelli, et al.
Tumori|May 1, 1995
Pain at tumor site after vinorelbine injection: description of an unexpected side effectM Colleoni, F Gaion, G Vicario, et al.
American Journal of Clinical Oncology|August 1, 1997
Phase II study of estramustine, oral etoposide, and vinorelbine in hormone-refractory prostate cancerM Colleoni, C Graiff, G Vicario, et al.
Oncology Reports|May 20, 2011
Intermittent continuous infusion of fluorouracil, low-dose oral leucovorin and oral etoposide in advanced gastric cancerM Colleoni, G Vicario, C Graiff, et al.
American Journal of Clinical Oncology|June 1, 1997
Activity of combination chemotherapy in brain metastases from breast and lung adenocarcinomaM Colleoni, C Graiff, P Nelli, et al.
Tumori|September 1, 1996
Response to chemotherapy of brain metastases from malignant pleural mesotheliomaM Colleoni, G Liessi, C Avventi, et al.
Tumori|April 30, 1980
[Cardiotoxicity induced by 5-fluorouracil. A case report]P Manente, R Buchberger, G Valmachino, et al.
La Clinica Terapeutica|July 15, 1981
[Cimetidine and primary hyperparathyroidism: failure of reduction of blood levels of parathyroid hormone in 5 cases of primary hyperparathyroidism]P Gasparoni, G Rota, D Fioretti, et al.
Pageof 5